Kutsch, N., Pallasch, C., Tausch, E., Böhme, V., Ritgen, M., Liersch, R., . . . Eichhorst, B. (2022). Efficacy and safety of the combination of tirabrutinib and entospletinib with or without obinutuzumab in relapsed chronic lymphocytic leukemia. HemaSphere, 6(4), . https://doi.org/10.1097/HS9.0000000000000692
Chicago-Zitierstil (17. Ausg.)Kutsch, Nadine, et al. "Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib with or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia." HemaSphere 6, no. 4 (2022). https://doi.org/10.1097/HS9.0000000000000692.
MLA-Zitierstil (9. Ausg.)Kutsch, Nadine, et al. "Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib with or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia." HemaSphere, vol. 6, no. 4, 2022, https://doi.org/10.1097/HS9.0000000000000692.